Use of the abatacept in a patient with psoriatic arthritis

Revista Brasileira de Reumatologia

Volumn 50, Issue 3, 2010, Pages 343-345

  Rodrigues, Carlos Ewerton Maia ^a   Vieira, Francisco José Fernandes ^b   Callado, Maria Roseli Monteiro ^c   Gomes, Kirla Wagner Poti ^b   de Andrade, José Eyorand Castelo Branco ^b   Vieira, Walber Pinto ^d  

^a HOSPITAL GERAL DE FORTALEZA   (Brazil)

^b Rheumatology Department of HGF

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Rheumatology Department of HGF

Author keywords

Abatacept; Drug induced hepatitis; Psoriatic arthritis; Tuberculosis

Indexed keywords

ABATACEPT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ISONIAZID; LEFLUNOMIDE; METHOTREXATE; PREDNISONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; ANTIBODY CONJUGATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASTHENIA; CASE REPORT; CHEMOPROPHYLAXIS; CHOLURIA; DOSE RESPONSE; DRUG DOSE INCREASE; EDEMA; FEMALE; HEEL PAIN; HUMAN; JOINT BIOPSY; KNEE ARTHRITIS; KNEE ARTHROSCOPY; LABORATORY TEST; LATENT TUBERCULOSIS; PSORIATIC ARTHRITIS; SIDE EFFECT; SYNOVITIS; THORAX RADIOGRAPHY; TOXIC HEPATITIS; VISUAL ANALOG SCALE; DRUG ANTAGONISM; MIDDLE AGED;

ARTHRITIS, PSORIATIC; FEMALE; HUMANS; IMMUNOCONJUGATES; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954735680     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Moll JMH, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973; 3:55-78.
2. Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005; 64:14-7.
3. Lam GK, Bingham CO. In: Imboden J, Hellmann D, Stone J (eds.). Current Rheumatology Diagnosis and Treatment. 2nd ed. Lange Medical Books/ McGraw-Hill, 2007.
4. Mease PJ. In: Klippel JH, Stone JH, Crofford LJ, White PH (eds.). Primer on the Rheumatic Diseases. 3th ed. Springer/Arthritis Foundation, 2008.
5. Veale D, Ritchlin C, Fitz GO. Immunopathology of psoriasis and psoriatic arthritis. Ann Rheum Dis 2005; 65:26-9.
6. Jenkins MK, Taylor PS, Norton SD, Urdahl KB. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J Immunol 1991; 147:2461-6.
7. Salomon B, Bluestone JA. Complexities of CD28/B7:CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Reu Immunol 2001; 19:221-52.
8. Kaltwasser JP, Nash P, Gladman D, Roseri CF, Behsens F, Jones P et al. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial. Arthritis Rheum 2004; 50(6):1939-50.
9. Turkiewicz AM, Moreland LW. Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options. Arthritis Rheum 2007; 56:1051-66.
10. Schiff MH, Keiserman M, Codding C, Songchanoen S, Berman A, Nayiager S et al. Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomized, double-bind, placebo-controlloded study in patients with rheumatoid arthritis an inadequate response to methotrexate. Ann Rheum Dis 2008; 67(8):1096-103.
11. Schiff MH, Pritchard C, Huffstutter JE, Rodriguez-Valverde V, Durez P, Zhou X et al. Ann Rheum Dis published online 15 dec 2008. Disponível em http://ard.bmj.com/cgi/content/abstract/ard.2008.099218v1/fulltext.pdf. [Acesso em 14 de julho de 2009].
12. ClinicalTrials.gov [http://clinicaltrials.gov/]. A service of the U S National Institutes of Health. Disponível em http://clinicltrials.gov/show/NCT00534313. [Acesso em 13 de julho de 2009].
13. Abrams JR, Lebwohl MG, Guzzo CA, Jegasothy BV, Golfarb MT, Goffe BS et al. CTLA4Ig-mediated blokade of T-cell costimulation in pacients with psoriasis vulgaris. J Clin Invest 1999; 103(9):1243-52.
14. Kremer JM. Cytotoxic T-lymphocyte antigen4-immunoglobulin in rheumatoid arthritis. Rheum Dis Clin North Am 2004; 30:381-91.